Health Ministry Proposes Central Approval for Antimicrobials to Address Resistance
The Union Health Ministry has proposed amendments to the New Drugs and Clinical Trials Rules, 2019, to include antimicrobials in the definition of new drugs, requiring manufacturers to obtain prior approval from the Central Licensing Authority before applying for state manufacturing licences. This aims to strengthen regulatory oversight, ensuring quality, safety, and efficacy to combat antimicrobial resistance (AMR). The draft notifications also propose separate licensing for bulk drug wholesale and exemptions under Schedule M for select manufacturers. Public feedback is invited before finalization.
First-hand measurement across 6 sources
We measured how 6 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (61/100). Lens Score 55/100.
Outlets measured: thehindu, mint, businessstandard, economictimes, deccanherald, hindustantimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–70/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
hindustantimes broke this story on 19 Nov, 07:03 am. Other outlets followed.
